Immunomodulatory and Anti-Inflammatory Activity Induced by Oral Administration of a Probiotic Strain of Lactobacillus Casei
Open Access
- 1 January 2006
- journal article
- research article
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 4 (1), 31-41
- https://doi.org/10.1177/1721727x0600400104
Abstract
The aim of this work was to study the effect of the long-term cyclic administration of the probiotic strain of Lactobacillus (L.) casei CRL 431 as a mucosal immunomodulator of the immune cells associated with the lamina propria of the small intestine, bronchus and other immune cells not associated with mucosal tissues, such as peritoneal macrophages. BALB/c mice were orally administered with a suspension of Lc 109 cfu/day/animal in non-fat milk (NFM) 10% for two consecutive days, the optimal dose selected in previous studies to reach protective immunity. This administration was repeated cyclically every 5 days for 98 days. Mice in the control group received only NFM 10%. Samples were taken after two days of L. casei administration and every 14 days until day 98. The small intestine and lungs were removed for histological slices preparation. Haematoxilin-eosin stains were made for histological studies of the small intestine. The number of IgA producing cells in the lamina propria of the small intestine and in bronchus was determined by immunofluorescence assays. Regulatory (IL-4, IL-10) and proinflammatory (TNF-α, INF-γ) cytokines were measured in the gut. Peritoneal macrophages were collected during the same periods for phagocytosis assays. We determined an increase in the number of IgA+ cells in the lamina propria of the small intestine in all the periods assayed and in BALT only until day 28. The cytokines studied (IL-10, IL-4, TNF-α and INF-γ) increased in most of the periods assayed, the effect being more remarkable for the anti-inflammatory cytokines such as IL-4 and IL-10. INF-γ was also increased but no modifications in the histological studies of the small intestine were observed, suggesting other roles for this cytokine The phagocytic activity of PM increased for most of the periods assayed. We demonstrated that long-term cyclic oral L. casei administration favors mucosal immunity and modulates the immune response to maintain the homeostasis at the mucosal level.Keywords
This publication has 18 references indexed in Scilit:
- Let's go mucosal: communication on slippery groundTrends in Immunology, 2004
- Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulationJournal of Applied Microbiology, 2004
- Anatomical basis of tolerance and immunity to intestinal antigensNature Reviews Immunology, 2003
- Interaction of lactic acid bacteria with the gut immune systemEuropean Journal of Clinical Nutrition, 2002
- Developmental study of immunocompetent cells in the bronchus-associated lymphoid tissue (BALT) from Wistar ratsDevelopmental & Comparative Immunology, 2000
- Specific immunity Induction at the mucosal level by viablelactobacillus casei:a Perspective for oral vaccine developmentFood and Agricultural Immunology, 1998
- Comparative effect of the adjuvant capacity ofLactobacillus caseiand lipopolysaccharide on the intestinal secretory antibody response and resistance toSalmonellainfection in miceFood and Agricultural Immunology, 1995
- Potential of using lactic acid bacteria for therapy and immunomodulation in manFEMS Microbiology Reviews, 1993
- Antitumour activity of orally administeredlactobacillus casei:significance of its dose in the inhibition of a fibrosarcoma in miceFood and Agricultural Immunology, 1993
- Immunoadjuvant activity of oralLactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infectionsJournal of Dairy Research, 1991